![]() Whenever possible, providers should administer injected or intranasal live-virus vaccines on different days ≥28 days apart. Typically, the immune response is impaired only for the second live-virus vaccine administered. The immune response to an injected or intranasal live-virus vaccine (e.g., MMR, varicella, live attenuated influenza vaccines ), might be impaired if administered within 28 days of another live-virus vaccine. See COVID-19 vaccine and immunization information, including interim clinical considerations. Coronavirus Disease 2019 VaccinesĬoronavirus disease 2019 (COVID-19) vaccines can be administered concomitantly with any other vaccines. Injectable live vaccines should be administered at intervals of ≥28 days, if not administered simultaneously. Simultaneous administration of indicated vaccines is particularly advantageous for international travelers for whom exposure to several infectious diseases might be imminent. In general, most common vaccines can be given at the same visit, at separate injection sites, without impairing antibody responses or increasing rates of adverse reactions, except as outlined below. For information on vaccinating travelers with altered immune function, see Sec. The Advisory Committee on Immunization Practices (ACIP) website outlines recommendations, background, adverse reactions, precautions, and contraindications for vaccines and toxoids. For example, measles-mumps-rubella (MMR) vaccine is indicated for infants aged 6–11 months who travel abroad, and hepatitis A vaccine is indicated for some infants aged 6–11 months who travel abroad, whereas these vaccines are not routinely given before age 12 months in the United States. Some routine vaccinations are administered at earlier ages for international travelers. PPSV23 is recommended for all adults ≥65 years old. Herpes zoster (shingles) vaccine is recommended for adults aged ≥50 years old. ![]() Influenza vaccine routinely is recommended for all people aged ≥6 months each year. Routine vaccinations that are usually administered during childhood and adolescence in the United States include diphtheria, tetanus, pertussis (DTaP) Haemophilus influenzae type b (Hib) hepatitis A (HepA), hepatitis B (HepB) human papillomavirus (HPV) measles-mumps-rubella (MMR) meningococcal vaccine (MenACWY) pneumococcal disease, including pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) poliomyelitis (IPV) rotavirus and varicella. ![]() The pretravel health consultation is an opportunity to administer routine vaccines that are recommended based on age and other individual characteristics, and travel medicine practitioners should therefore be familiar with the general principles of vaccination and immunoprophylaxis. Post-Immunization Adverse Event Reporting.Vaccination Scheduling for Selected Travel Vaccines.Vaccinating People With Acute Illnesses.
0 Comments
Leave a Reply. |